Iperion (NZSE:IPR) Short-Term Debt: NZ$0.00 Mil (As of Mar. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

What is Iperion Short-Term Debt?

Iperion NZSE:IPR Short-Term Debt is NZ$0.00 Mil as of Mar. 2026. The stock has 1 warning sign investors should review.

Iperion's Short-Term Debt for the quarter that ended in Mar. 2026 was NZ$0.00 Mil.

Iperion Short-Term Debt Explanation

Short-Term Debt represents the total amount of Long-Term Debt such as bank loans and commercial paper, which is due within one year.

Iperion Short-Term Debt Related Terms

Iperion Short-Term Debt Historical Data

* Premium members only.

The historical data trend for Iperion's Short-Term Debt can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Iperion Short-Term Debt Chart

Iperion Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Short-Term Debt
Get a 7-Day Free Trial Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00

Iperion Semi-Annual Data
Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25 Mar26
Short-Term Debt Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
Frequently Asked Questions Learn more about Short-Term Debt →
What does a Short-Term Debt of NZ$0.00 Mil mean?
Iperion (NZSE:IPR) has a Short-Term Debt of NZ$0.00 Mil as of Mar. 2026.
Is Iperion's Short-Term Debt too high?
Iperion's current Short-Term Debt is NZ$0.00 Mil.
How does Iperion's Short-Term Debt compare to CCCX and CEPF?
Iperion's Short-Term Debt of NZ$0.00 Mil can be compared against companies in the Diversified Financial Services industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Short-Term Debt for a Diversified Financial Services company?
A good Short-Term Debt depends on the Diversified Financial Services industry context. However, Short-Term Debt should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Short-Term Debt mean?
A high Short-Term Debt can signal that a stock is expensive relative to its fundamentals. Iperion's current Short-Term Debt is NZ$0.00 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Iperion stock overvalued right now?
Iperion (NZSE:IPR) has a current Short-Term Debt of NZ$0.00 Mil. The current Short-Term Debt is NZ$0.00 Mil. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Short-Term Debt calculated?
Short-Term Debt is calculated from a company's financial statements. For Iperion (NZSE:IPR), the current Short-Term Debt is NZ$0.00 Mil as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Iperion Business Description

Address c/o Duncan Cotterill, 50 Customhouse Quay, Level 5 Tower Building, Wellington, NTL, NZL, 6011
Iperion Ltd is engaged in the process of commercializing a novel antimicrobial coating product, being marketed under the name Pathoglaze. The company is engaged in manufacturing, selling, distributing, importing, and exporting a self-cleaning, transparent, antimicrobial surface coating product.